EXACT Sciences Corporation (EXAS)
US$ 41.58-1.61%
Price Chart
Key Statistics
Market Cap
$ 8.47B
P/E Ratio
0.00
Revenue (TTM)
$ 2.76B
Volume
3.15M
52W High
$ 72.83
52W Low
$ 39.97
Dividend Yield
0.00%
Beta
1.14
Technicals
50-Day MA
45.7806
200-Day MA
55.7866
52 Week High
72.83
52 Week Low
39.97
About EXAS
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect.
Employees
6900
Headquarters
Madison, WI
CEO
Mr. Kevin T. Conroy J.D.
Latest News
Exact Sciences Schedules First Quarter 2025 Earnings Call - Business Wire
4 weeks ago • Google News
EXAS Quantitative Stock Analysis - Benjamin Graham - Nasdaq
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg